ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 66 filers reported holding ACUMEN PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $805 | -92.0% | 194 | -90.8% | 0.00% | – |
| Q2 2023 | $10,105 | -19.6% | 2,101 | -32.1% | 0.00% | – |
| Q1 2023 | $12,570 | +29.8% | 3,096 | +72.7% | 0.00% | – |
| Q4 2022 | $9,682 | -53.9% | 1,793 | -14.2% | 0.00% | – |
| Q3 2022 | $21,000 | +950.0% | 2,090 | +266.7% | 0.00% | – |
| Q2 2022 | $2,000 | -81.8% | 570 | -79.4% | 0.00% | – |
| Q1 2022 | $11,000 | -21.4% | 2,773 | +33.6% | 0.00% | – |
| Q4 2021 | $14,000 | +1300.0% | 2,075 | +3968.6% | 0.00% | – |
| Q3 2021 | $1,000 | – | 51 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $18,452 | 5.05% |
| Knollwood Investment Advisory, LLC | 1,678,510 | $9,063,954 | 3.55% |
| GUARDIAN POINT CAPITAL, LP | 300,000 | $1,620,000 | 1.28% |
| GREAT POINT PARTNERS LLC | 1,116,581 | $6,029,537 | 1.18% |
| RA Capital Management | 9,770,773 | $52,762,174 | 1.07% |
| Deep Track Capital, LP | 3,952,000 | $21,340,800 | 0.90% |
| Cheyne Capital Management (UK) LLP | 55,829 | $301,477 | 0.53% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 295,115 | $1,593,621 | 0.46% |
| COMMODORE CAPITAL LP | 498,315 | $2,691 | 0.41% |
| Ikarian Capital, LLC | 254,945 | $1,376,703 | 0.33% |